8 results
DRS
IKNA
Ikena Oncology Inc
8 Jan 21
Draft registration statement
12:00am
developments in clinical trials of products conducted by others may cause the FDA or other oversight bodies to change the requirements for approval of any … to comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation
8-K
EX-1.1
qksxp2qlrgkk4
15 May 23
Ikena Oncology Reports First Quarter 2023 Financial Results and Highlights Advancements Across
9:09am
8-K
EX-2.1
mr82sb68gh
7 Aug 23
Ikena Oncology Acquires Pionyr Immunotherapeutics in All-Stock Transaction
8:02am
- Prev
- 1
- Next